Bayer

News

Bayer CEO says recovery on track as key drug products shine

Bayer has joined its peers among European drugmakers with a hike in pharma forecasts for the year, as it recorded a rise in group sales, but lower profits for the second quarter.

News

Bayer's finerenone clears key heart failure trial

At the start of this year, Bayer said there were two important trial readouts for the company to deliver near-term growth this year as it rebuilds its pipeline – and both have now delivered

News

Bayer files first application of menopause drug elinzanetant

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights.

News

Trial sets up wider use of Bayer's Nubeqa in prostate cancer

Bayer has the result it was hoping for in the phase 3 ARANOTE trial of Nubeqa in metastatic, hormone-sensitive prostate cancer (mHSPC), a key part of its plan to build the drug into a €3 bi

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

News

Bayer taps Samsung wearables for menopause sleep study

Sleep disturbances are one of the most common and disruptive symptoms in menopausal women, but not enough is known about the causes, and current sleep aids are often ineff

Bayer CEO says recovery on track as key drug products shine

Bayer's finerenone clears key heart failure trial

Bayer files first application of menopause drug elinzanetant

Trial sets up wider use of Bayer's Nubeqa in prostate cancer

FDA widens label for BMS’ cancer drug Augtyro

Bayer taps Samsung wearables for menopause sleep study

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Bayer

Editor's Picks